Kalvista Pharmaceuticals Inc (KALV) — Cash Flow Reinvestment Rate

Latest as of January 2018: 0.01x

Kalvista Pharmaceuticals Inc (KALV) has a Cash Flow Reinvestment Rate of 0.01x as of January 2018, reinvesting $182.00K (capex $182.00K ) from operating cash flow of $28.22 Million. See free cash flow generation of Kalvista Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.01x
(Capex + Investments) / Operating CF

Total Reinvested

$182.00K
Capex + Investments

Operating Cash Flow

$28.22 Million
USD

Capital Expenditures

$182.00K
USD

Kalvista Pharmaceuticals Inc Cash Flow Reinvestment Rate (2018–2018)

Historical reinvestment intensity for Kalvista Pharmaceuticals Inc across 1 annual periods. For the full cash flow conversion analysis, see KALV operating cash flow.

Annual Cash Flow Reinvestment Rate for Kalvista Pharmaceuticals Inc (2018–2018)

Year-by-year capital reinvestment analysis for Kalvista Pharmaceuticals Inc. See KALV free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2018 0.27x $2.85 Million $10.56 Million $1.43 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow